TimesSquare Capital Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

TimesSquare Capital Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,227,503	Closed	-$20.8M	–	269
2014 Q4	$20.8M	Sell	1,227,503 -2,218,750	-64%	-$31.2M	0.12%	205
2014 Q3	$41.1M	Sell	3,446,253 -519,000	-13%	-$3.54M	0.23%	154
2014 Q2	$22.4M	Sell	3,965,253 -230,425	-5%	-$1.06M	0.12%	206
2014 Q1	$15.4M	Sell	4,195,678 -34,300	-0.8%	-$131K	0.08%	217
2013 Q4	$14.2M	Buy	4,229,978 +365,800	+9%	+$1.51M	0.07%	213
2013 Q3	$16.3M	Sell	3,864,178 -397,300	-9%	-$1.88M	0.09%	217
2013 Q2	$19.6M	Buy	+4,261,478	New	+$14.6M	0.12%	213

TimesSquare Capital Management's AVNR Position: Q1 2015 in Review

TimesSquare Capital Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,227,503 shares — an estimated $20.8M sold.

TimesSquare Capital Management first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $41.1M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

TimesSquare Capital Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
TimesSquare Capital Management sold 1,227,503 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $20.8M.
TimesSquare Capital Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
TimesSquare Capital Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $41.1M in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on TimesSquare Capital Management's 13F filing for Q1 2015, filed 12 May 2015.